Subcutaneous fat in normal and diseased states - 1. Introduction

被引:40
作者
Avram, MM
Avram, AS
James, WD
机构
[1] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Dermatol, Boston, MA USA
[2] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
关键词
D O I
10.1016/j.jaad.2005.05.014
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
In recent years, our understanding of adipose tissue physiology and function has undergone an enormous transformation. Once considered a passive storage receptacle with a fixed number of cells and limited purpose, adipose tissue is now recognized as a complicated organ with important endocrine and metabolic functions. It is now known that both increased and decreased adipose tissue mass, as seen in obesity, anorexia, and lipodystrophy, have profound effects on multiple body systems, including immune, reproductive, and hematopoietic. The study of adipose tissue, therefore, is important not only for those who treat obesity, lipoatrophy, and their associated metabolic and endocrine derangements, but also for those dermatologists who specialize in the medical and surgical treatment of disorders within the body's largest adipose tissue subdivision, the subcutaneous fat. This introductory article is the first in a series about adipose tissue in normal and diseased states.
引用
收藏
页码:663 / 670
页数:8
相关论文
共 92 条
[1]   The Bcl-2 protein family: Arbiters of cell survival [J].
Adams, JM ;
Cory, S .
SCIENCE, 1998, 281 (5381) :1322-1326
[2]  
AILHAUD G, 1991, INT J OBESITY, V15, P87
[3]  
AILHAUD G, 1980, RECENT ADV OBESITY R, P174
[4]   Annual deaths attributable to obesity in the United States [J].
Allison, DB ;
Fontaine, KR ;
Manson, JE ;
Stevens, J ;
VanItallie, TB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (16) :1530-1538
[5]   Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997) - The Minnesota Heart Survey [J].
Arnett, DK ;
McGovern, PG ;
Jacobs, DR ;
Shahar, E ;
Duval, S ;
Blackburn, H ;
Luepker, RV .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (10) :929-935
[6]  
Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrg862, 10.1038/nrn902]
[7]   The adipocyte-secreted protein Acrp30 enhances hepatic insulin action [J].
Berg, AH ;
Combs, TP ;
Du, XL ;
Brownlee, M ;
Scherer, PE .
NATURE MEDICINE, 2001, 7 (08) :947-953
[8]  
BJORNTORP P, 1991, INT J OBESITY, V15, P67
[9]  
Bjorntorp P, 1974, Horm Metab Res, VSuppl 4, P77
[10]   Medicinal strategies in the treatment of obesity [J].
Bray, GA ;
Tartaglia, LA .
NATURE, 2000, 404 (6778) :672-677